Connecticut Wealth Management »

Rigel Pharmaceuticals shares owned by Connecticut Wealth Management

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Connecticut Wealth Management from 13F filings

Historical chart of Connecticut Wealth Management investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Connecticut Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Connecticut Wealth Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $216k 12k 18.73
2025-03-31 $207k 12k 17.99
2024-12-31 $194k 12k 16.82
2024-09-30 $186k 12k 16.18
2024-06-30 $95k 12k 8.22

More positions owned by Connecticut Wealth Management

Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Growth Etf (VUG)
Ishares Core Msci Emkt (IEMG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Small Cp Etf (VB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Raytheon Technologies Corp (RTX)

View all positions for Connecticut Wealth Management

Top funds holding Rigel Pharmaceuticals

BlackRock
Vanguard Group
Goldman Sachs Group
Armistice Capital
Acadian Asset Management
Marshall Wace
Capitolis Liquid Global Markets
State Street Corporation
Renaissance Technologies
Geode Capital Management
Qube Research & Technologies
Jane Street
Soleus Capital Management
D. E. Shaw & Co
Hillsdale Investment Management

View all funds holding Rigel Pharmaceuticals